Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/14/1995 | WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy |
12/14/1995 | WO1995033839A1 Recombinant leukotriene-c4 synthase |
12/14/1995 | WO1995033838A1 Microorganisms permitting the intracellular polyhydroxy alkanoate synthesis with simultaneous extracellular polysaccharide synthesis and processes for producing the same |
12/14/1995 | WO1995033837A1 Purified scytalidium laccases and nucleic acids encoding same |
12/14/1995 | WO1995033836A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
12/14/1995 | WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | WO1995033834A1 Lag1: a gene for increasing the longevity of eukaryotes |
12/14/1995 | WO1995033833A1 Yeast strains |
12/14/1995 | WO1995033832A1 Recombinant single chain fv antibody fragment and its use in the immunopurification of the recombinant hepatitis b virus surface antigen |
12/14/1995 | WO1995033831A1 Methods and compositions for modulating morphogenic protein expression |
12/14/1995 | WO1995033830A1 Bmp-9 compositions |
12/14/1995 | WO1995033829A1 Pantropic neurotrophic factors |
12/14/1995 | WO1995033828A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants |
12/14/1995 | WO1995033827A1 Magnetic bead precipitation method |
12/14/1995 | WO1995033826A1 Transgenic mice expressing progressive cervico-vaginal neoplasia |
12/14/1995 | WO1995033825A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
12/14/1995 | WO1995033824A1 Method for increasing transduction of cells by adeno-associated virus vectors |
12/14/1995 | WO1995033823A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | WO1995033820A1 Transgenic mice expressing progressive epithelial neoplasia |
12/14/1995 | WO1995033818A2 Genes for the synthesis of antipathogenic substances |
12/14/1995 | WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
12/14/1995 | WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
12/14/1995 | WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | WO1995033767A1 Helicobacter pylori nickel binding protein |
12/14/1995 | WO1995033759A2 Antisense oligonucleotides and methods for the treatment of schistosomiasis |
12/14/1995 | WO1995033758A1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
12/14/1995 | WO1995033493A1 Novel uses of triplex forming oligonucleotides for the treatment of human diseases |
12/14/1995 | WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
12/14/1995 | WO1995033479A1 Cytotoxic enhancement of tnf with copper |
12/14/1995 | WO1995031564A3 Method of introducing pathogen resistance in plants |
12/14/1995 | WO1995030011A3 Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
12/14/1995 | WO1995030003A3 Morphogenic protein-specific cell surface receptors and uses therefor |
12/14/1995 | WO1995029241A3 Ribozymes with product ejection by strand displacement |
12/14/1995 | WO1995027063A3 Rfb retrovirus genome |
12/14/1995 | DE4417598A1 Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen Use of the regulated stringently Tetracyclinpromotors for production of recombinant proteins in prokaryotic cells |
12/14/1995 | CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
12/14/1995 | CA2192468A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
12/14/1995 | CA2192370A1 Monoclonal antibody active against cd44v6 |
12/14/1995 | CA2192366A1 Genes for the synthesis of antipathogenic substances |
12/14/1995 | CA2192312A1 Helicobacter pylori nickel binding protein |
12/14/1995 | CA2192214A1 Method for increasing transduction of cells by adeno-associated virus vectors |
12/14/1995 | CA2191891A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants |
12/14/1995 | CA2191880A1 Method and probes for detecting markers bound to the locus of child spinal muscular atrophies |
12/14/1995 | CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | CA2191718A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
12/14/1995 | CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | CA2191586A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system |
12/14/1995 | CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain |
12/14/1995 | CA2191104A1 Lag1: a gene for increasing the longevity of eukaryotes |
12/14/1995 | CA2189546A1 Use of a specific marker for detection of salmonella with pcr |
12/14/1995 | CA2174748A1 Fingerprinting of nucleic acids, products and methods |
12/13/1995 | EP0686699A2 Apparatus and method for determining the concentration of the target nucleic acid in PCR |
12/13/1995 | EP0686697A2 Method for the enrichment of cells modified by ballistic transfer |
12/13/1995 | EP0686696A1 Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant Hepatitis B Virus Surface Antigen |
12/13/1995 | EP0686695A1 Rat protein kinare C and production thereof |
12/13/1995 | EP0686692A2 Use of alcaline proteases in industrial textil washing processes |
12/13/1995 | EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons |
12/13/1995 | EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
12/13/1995 | EP0686202A1 Prenatal screening |
12/13/1995 | EP0686200A1 Amplification of nucleic acid sequences |
12/13/1995 | EP0686197A1 Geminivirus-based gene expression system |
12/13/1995 | EP0686196A1 Plant virus resistance conferring polyribozyme and resistant plants producing same |
12/13/1995 | EP0686195A1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
12/13/1995 | EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof |
12/13/1995 | EP0686193A1 Alkali-tolerant xylanases |
12/13/1995 | EP0686191A1 Controlled modification of eukaryotic genomes |
12/13/1995 | EP0686162A1 Improved method for the refolding of proteins |
12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
12/13/1995 | EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
12/13/1995 | EP0359771B1 Lepidopteran and coleopteran active microorganisms, related insecticide compositions and methods for their production and use |
12/13/1995 | CN1113390A Defective adenovirus vectors and use thereof in gene therapy |
12/13/1995 | CN1113389A High molecular weight desulphatohirudin |
12/12/1995 | US5475610 Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
12/12/1995 | US5475101 Culture product of Trichoderma |
12/12/1995 | US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells |
12/12/1995 | US5475099 Plant fatty acid synthases |
12/12/1995 | US5475097 Lysine-specific Porphyromonas gingivalis proteinase |
12/12/1995 | US5475096 Binding to three-dimensional targets |
12/12/1995 | US5475094 Salmycins, a process for their preparation and their use as a pharmaceutical |
12/12/1995 | US5475091 Monoclonal antibodies produced by a hybridoma cell; antiinflammatory agents |
12/12/1995 | US5475090 Gene coded for a polypeptide which enhances virus infection of host insects |
12/12/1995 | US5475087 Polypeptides |
12/12/1995 | US5474982 PDGF analogs and methods of use |
12/12/1995 | US5474981 Use of the cytokine IP-10 as an anti-tumor agent |
12/12/1995 | US5474935 Adeno-associated virus (AAV)-based eucaryotic vectors |
12/12/1995 | US5474933 An isolated nucleic acid from gram-negative bacteria SHEWANELLA involved in tyrosine conversion to melanin pigment |
12/12/1995 | US5474930 Non-tumorigenic cell lines for expression of genes |
12/12/1995 | US5474929 Selectable/reporter gene for use during genetic engineering of plants and plant cells |
12/12/1995 | US5474928 Arginine deiminase from a Mycoplasma arginini strain |
12/12/1995 | US5474925 Creating genetic construction for expression of enzyme in cotton plant, transforming into inheritable material of plant, cultivating plant, harvesting seed floss fiber with enzyme immobilized therein, performing reaction with enzyme catalyst |
12/12/1995 | US5474922 β-1,4-galactanase and a DNA sequence |
12/12/1995 | US5474921 Expression and purification of phosphoinositide-specific phospholipase C-γ |
12/12/1995 | US5474920 Lack 5'-3' exonuclease activity of native enzyme which enables improved methods of conducting polymerase chain reactions, DNA sequencing amd DNA synthesis |
12/12/1995 | US5474917 From starch |
12/12/1995 | US5474916 Complexing, hybridizing |
12/12/1995 | US5474914 Method of producing secreted CMV glycoprotein H |
12/12/1995 | US5474913 Process for the preparation of motilin-like polypeptide and expression thereof |
12/12/1995 | US5474912 Method for increasing production of microbial metabolites by genetic engineering |